Data / Drug companies / Teriflunomide
Teriflunomide: 17 companies and 36 products in the FDA NDC directory
Teriflunomide is listed in the FDA National Drug Code Directory by 17 companies, with 36 products in commercial distribution. 34 of the products (94.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on October 26, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 36
- Generic (ANDA) products
- 34 (94.4%)
- Application numbers
- 13
- Routes
- Oral
- Brand names
- Aubagio
- openFDA record search
- api.fda.gov
Companies that list teriflunomide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| MSN Laboratories Private Limited | 4 | tablet, film coated | Generic drugs (ANDA) | April 24, 2019 |
| Accord Healthcare Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 13, 2023 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | January 25, 2023 |
| Alembic Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | January 25, 2023 |
| Aurobindo Pharma Limited | 2 | tablet | Generic drugs (ANDA) | February 28, 2023 |
| AvKARE | 2 | tablet, film coated | Generic drugs (ANDA) | April 20, 2023 |
| Biocon Pharma Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 13, 2023 |
| Camber Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 13, 2023 |
| CivicaScript LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 26, 2026 |
| Concord Biotech Limited | 2 | tablet, film coated | Generic drugs (ANDA) | July 7, 2025 |
| Genzyme Corporation | 2 | tablet, film coated | New drug applications (NDA) | May 1, 2013 |
| Glenmark Pharmaceuticals Inc., USA | 2 | tablet, film coated | Generic drugs (ANDA) | January 19, 2023 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | February 14, 2023 |
| Natco Pharma USA LLC | 2 | tablet | Generic drugs (ANDA) | June 17, 2023 |
| Teva Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 13, 2023 |
| Zydus Lifesciences Limited | 2 | tablet, film coated | Generic drugs (ANDA) | February 14, 2023 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | February 14, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 32 | 88.9% |
| Tablet | 4 | 11.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 34 | 94.4% |
| New drug applications (NDA) | 2 | 5.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Pyrimidine Synthesis Inhibitor | 36 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.